Dr. Suneet Grewal, MD
Claim this profileEast Bay Rheumatology Medical Group, Inc
Studies Arthritis
Studies Rheumatoid Arthritis
7 reported clinical trials
13 drugs studied
Affiliated Hospitals
Clinical Trials Suneet Grewal, MD is currently running
Long-Term Safety of Secukinumab
for Autoimmune Inflammation
The purpose of this study is to assess long term safety in participants who have completed a Novartis trial with secukinumab, have been judged by the investigator to benefit from continued treatment with secukinumab, and are unable to obtain the marketed secukinumab formulation.
Recruiting3 awards Phase 45 criteria
Pegloticase + Methotrexate
for Gout
The study consists of 24-week double-blind trial to evaluate the non-inferiority of the efficacy and safety of pegloticase Q4W with MTX versus pegloticase Q2W with MTX, followed by a 24-week open-label extension of pegloticase Q4W with MTX, in participants with uncontrolled refractory gout. The main objective of the study is to evaluate the effect of pegloticase 16 mg administered Q4W with MTX versus pegloticase 8 mg administered Q2W with MTX, on the response rate during Month 6, as measured by the sustained normalization of sUA to \< 6 mg/dL for at least 80% of the time.
Recruiting3 awards Phase 4
More about Suneet Grewal, MD
Clinical Trial Related2 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Suneet Grewal, MD has experience with
- Pegloticase
- Deucravacitinib
- Methotrexate
- Baricitinib
- TNF Inhibitor
- GSK3196165 (Otilimab)
Breakdown of trials Suneet Grewal, MD has run
Arthritis
- Peresolimab for Rheumatoid Arthritis
- Baricitinib for Rheumatoid Arthritis
- Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic (cs)/Biologic (b) Disease Modifying Anti-rheumatic Drugs (DMARDs)
Rheumatoid Arthritis
- Peresolimab for Rheumatoid Arthritis
- Baricitinib for Rheumatoid Arthritis
- Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic (cs)/Biologic (b) Disease Modifying Anti-rheumatic Drugs (DMARDs)
Systemic Lupus Erythematosus
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Suneet Grewal, MD specialize in?
Suneet Grewal, MD focuses on Arthritis and Rheumatoid Arthritis. In particular, much of their work with Arthritis has involved treating patients, or patients who are undergoing treatment.
Is Suneet Grewal, MD currently recruiting for clinical trials?
Yes, Suneet Grewal, MD is currently recruiting for 4 clinical trials in San Leandro California. If you're interested in participating, you should apply.
Are there any treatments that Suneet Grewal, MD has studied deeply?
Yes, Suneet Grewal, MD has studied treatments such as Pegloticase, Deucravacitinib, Methotrexate.
What is the best way to schedule an appointment with Suneet Grewal, MD?
Apply for one of the trials that Suneet Grewal, MD is conducting.
What is the office address of Suneet Grewal, MD?
The office of Suneet Grewal, MD is located at: East Bay Rheumatology Medical Group, Inc, San Leandro, California 94578 United States. This is the address for their practice at the East Bay Rheumatology Medical Group, Inc.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.